Stock Events

Green Life Science. 

₩1,790
2
+₩0+0% Friday 06:30

Statistics

Day High
1,800
Day Low
1,783
52W High
2,825
52W Low
1,774
Volume
24,830
Avg. Volume
19,726
Mkt Cap
34.74B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Apr 18
₩100
Aug 17
₩134
Jun 13
₩100
Apr 13
₩500
Aug 12
₩100
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

31DecConfirmed
Q1 2017
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
-117.08
-52.14
12.81
77.76
Expected EPS
N/A
Actual EPS
-117.0821

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 114450.KQ. It's not an investment recommendation.
Alphabet
68918
GOOGL
Apple
60554
AAPL
Microsoft
56693
MSFT
Amazon
51850
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Celltrion Pharm
068760.KQ
Mkt Cap3.83T
Celltrion Pharm Inc. focuses on the development and production of pharmaceuticals, directly competing in the biopharmaceutical sector with Green Life Science.
Seegene
096530.KQ
Mkt Cap970.44B
SillaJen, Inc. works on oncolytic virotherapy products, a niche but directly competitive field to Green Life Science's therapeutic solutions.
Celltrion Health Care
091990.KQ
Mkt Cap11.33T
Celltrion Healthcare conducts the marketing and distribution of biopharmaceutical products, competing in the commercialization aspect of the biopharma sector.
Medy-Tox
086900.KQ
Mkt Cap1.24T
Medy-Tox Inc. focuses on biopharmaceutical products and medical devices, sharing market space and technological competition with Green Life Science.
Ildong Pharm
249420.KQ
Mkt Cap0
NeoPharm Co., Ltd. is involved in the development and manufacturing of dermatological products, competing in a similar biotech niche as Green Life Science.

About

KPX Lifescience.Co.,Ltd. engages in development, production, and sale of agrochemical raw materials and pharmaceutical intermediates in South Korea and internationally. The company offers raw materials for pharmaceuticals, pesticides, and primary intermediates to the pharmaceutical and agrochemical markets. It also develops EDP-CL, an intermediate for piperacillin-based antibiotics, including N,N-disuccinimidyl carbonate used for the synthesis of HIV treatment; Amoxapine, an antidepressant raw material; and AM19, an antibiotic intermediate. The company was formerly known as MNH Laboratories Co., Ltd. and changed its name to KPX Lifescience.Co.,Ltd. in September 2008. The company was founded in 2005 and is headquartered in Yeosu, South Korea. KPX Lifescience.Co.,Ltd. is a subsidiary of KPX Holdings Co., Ltd.
Show more...
CEO
Jun-Yeong Yang
Country
KR
ISIN
KR7114450000

Listings

KQ
KR
114450.KQ